Townsend & Associates’s VivoSim Labs VIVS Stock Holding History

Townsend & Associates’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	151
2018 Q3	$0	Hold	1	–	–	﹤0.01%	170
2018 Q2	$0	Hold	1	–	–	﹤0.01%	180
2018 Q1	$0	Buy	+1	New	+$292	﹤0.01%	202

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Townsend & Associates's VIVS Position: Q4 2018 in Review

Townsend & Associates sold out of VivoSim Labs (VIVS) in Q4 2018, closing a stake of 1 share.

Townsend & Associates first reported a position in VIVS in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 114 funds tracked by Wall St. Rank hold VIVS as of Q4 2018.

Townsend & Associates reported no remaining VivoSim Labs position as of Q4 2018 after selling out during the quarter.
Townsend & Associates sold 1 VivoSim Labs share in Q4 2018.
Townsend & Associates first reported a position in VivoSim Labs in Q1 2018 and held it in 3 quarters.
Townsend & Associates's VivoSim Labs position peaked at $0 in Q3 2018.
114 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2018.

Based on Townsend & Associates's 13F filing for Q4 2018, filed 15 Jan 2019.